Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TXNRD1 Antikörper (AA 161-647)

TXNRD1 Reaktivität: Human WB, ELISA, ICC, IF Wirt: Maus Monoclonal AT30F1 unconjugated
Produktnummer ABIN5776265
  • Target Alle TXNRD1 Antikörper anzeigen
    TXNRD1 (Thioredoxin Reductase 1 (TXNRD1))
    Bindungsspezifität
    • 15
    • 9
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 161-647
    Reaktivität
    • 40
    • 27
    • 25
    Human
    Wirt
    • 38
    • 4
    • 1
    Maus
    Klonalität
    • 33
    • 10
    Monoklonal
    Konjugat
    • 18
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser TXNRD1 Antikörper ist unkonjugiert
    Applikation
    • 32
    • 13
    • 13
    • 12
    • 8
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)
    Immunogen
    Recombinant human TXNRD1 (161-647aa) purified from E. coli
    Klon
    AT30F1
    Isotyp
    IgG2b kappa
    Top Product
    Discover our top product TXNRD1 Primärantikörper
  • Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/mL
    Lagerung
    4 °C,-20 °C,-80 °C
    Informationen zur Lagerung
    Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.
  • Target
    TXNRD1 (Thioredoxin Reductase 1 (TXNRD1))
    Andere Bezeichnung
    Thioredoxin Reductase 1/TRXR1 (TXNRD1 Produkte)
    Hintergrund
    TXNRD1, also known as Thioredoxin reductase 1, is a part of a selenium-containing pyridine nucleotidedisulphide oxidoreductase family, which has a conserved catalytic site of Cys-Val-Asn-Val-Gly-Cys. This protein reduces thioredoxins as well as other substrates, and plays a role in selenium metabolism and protection against oxidative stress. Inhibition of TXNRD1 activity may provide for potential treatments of cancer, AIDS and other autoimmune diseases as well as bacterial infections and parasitic diseases.
    NCBI Accession
    NP_001087240
    Pathways
    Regulation of Lipid Metabolism by PPARalpha, Regulation of Carbohydrate Metabolic Process, Cell RedoxHomeostasis
Sie sind hier:
Kundenservice